UnitedHealth Group Incorporated $UNH Shares Sold by Riverview Trust Co

Key Points

• Riverview Trust Co sold 751 shares of UnitedHealth Group (NYSE:UNH), reducing its holdings by 85.7% to 125 shares, which were valued at $39,000 at the end of the quarter.
• Institutional investors like Nuveen LLC and Vanguard Group have significantly increased their positions in UnitedHealth Group, indicating strong interest in the stock.
• Despite a recent earnings miss, analysts have set price targets for UnitedHealth Group shares, with a consensus rating of "Moderate Buy" and an average target price of $358.95.

Riverview Trust Co decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 85.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 125 shares of the healthcare conglomerate's stock after selling 751 shares during the quarter. Riverview Trust Co's holdings in UnitedHealth Group were worth $39,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Nuveen LLC purchased a new stake in UnitedHealth Group during the 1st quarter worth $3,846,764,000. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP raised its position in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. National Bank of Canada FI raised its position in shares of UnitedHealth Group by 137.8% in the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock valued at $859,518,000 after purchasing an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after buying an additional 847,054 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of several recent analyst reports. Truist Financial raised their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a report on Tuesday, September 9th. Bank of America upped their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. Piper Sandler lowered their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Sanford C. Bernstein lifted their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Finally, Barclays raised their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Stock Up 0.7%

UNH stock opened at $347.82 on Thursday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm's 50-day simple moving average is $304.76 and its 200 day simple moving average is $357.57. The stock has a market cap of $315.01 billion, a PE ratio of 15.07, a price-to-earnings-growth ratio of 2.25 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.